Oxford University – AstraZeneca Publish Positive Coronavirus Vaccine Data in Lancet Study

Oxford University – AstraZeneca Publish Positive Coronavirus Vaccine Data in Lancet Study
Spread the love

Oxford University, along with Britain’s AstraZeneca plc  (AZN) – Get Report published promising data from an early stage trial of a key coronavirus vaccine study Monday in London that could lead to its broader use before the end of the year.

The details, published in the U.K. medical journal The Lancet, showed what the two groups described as humoral and cellular immune responses in human trials, with an acceptable safety profile. The study also showed ‘potent’ cellular and humoral immunogenicity in all 1,077 participants in the Phase 1/Phase II study.



Original Author

Please follow and like us:
editor

editor

Live Updates COVID-19 CASES
RSS
Follow by Email